Ketamine for Methamphetamine Use Disorder | MicrobiomeTrials← Back to trialsNCT06496750
Ketamine for Methamphetamine Use Disorder
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2024-09-11Est. Completion: 2026-09-06
Enrollment target: 120 participants Locations- Alameda Health System, San Leandro, California, United States
- Interdisciplinary Substance Use and Brain Injury Facility, Albuquerque, New Mexico, United States
- Addiction Institute of Mount Sinai, New York, New York, United States
- Prisma Health, Greenville, South Carolina, United States
- UT Southwestern Medical Center, Dallas, Texas, United States
Other microbiome trials you might be interested in
Substance Use Disorders (SUDs)
Background:
A Timeline Follow-Back (TLFB) is a tool that helps researchers track how much of a substance a person uses.…
Baltimore, United StatesCompleted May 31, 2027
Hereditary Hemorrhagic TelangiectasiaEpistaxisAnemiaNosebleedHHT
During the Efficacy Study (Part B), the investigators will study whether Pazopanib, taken daily for 24 weeks, will reduc…
Los Angeles, United StatesCompleted Nov 21, 2025